Literature DB >> 20159777

Human neural stem cells: a model system for the study of Lesch-Nyhan disease neurological aspects.

Silvia Cristini1, Stefania Navone, Laura Canzi, Francesco Acerbi, Emilio Ciusani, Uros Hladnik, Paola de Gemmis, Giulio Alessandri, Augusto Colombo, Eugenio Parati, Gloria Invernici.   

Abstract

The study of Lesch-Nyhan-diseased (LND) human brain is crucial for understanding how mutant hypoxanthine-phosphoribosyltransferase (HPRT) might lead to neuronal dysfunction. Since LND is a rare, inherited disorder caused by a deficiency of the enzyme HPRT, human neural stem cells (hNSCs) that carry this mutation are a precious source for delineating the consequences of HPRT deficiency and for developing new treatments. In our study we have examined the effect of HPRT deficiency on the differentiation of neurons in hNSCs isolated from human LND fetal brain. We have examined the expression of a number of transcription factors essential for neuronal differentiation and marker genes involved in dopamine (DA) biosynthetic pathway. LND hNSCs demonstrate aberrant expression of several transcription factors and DA markers. HPRT-deficient dopaminergic neurons also demonstrate a striking deficit in neurite outgrowth. These results represent direct experimental evidence for aberrant neurogenesis in LND hNSCs and suggest developmental roles for other housekeeping genes in neurodevelopmental disease. Moreover, exposure of the LND hNSCs to retinoic acid medium elicited the generation of dopaminergic neurons. The lack of precise understanding of the neurological dysfunction in LND has precluded development of useful therapies. These results evidence aberrant neurogenesis in LND hNSCs and suggest a role for HPRT gene in neurodevelopment. These cells combine the peculiarity of a neurodevelopmental model and a human, neural origin to provide an important tool to investigate the pathophysiology of HPRT deficiency and more broadly demonstrate the utility of human neural stem cells for studying the disease and identifying potential therapeutics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20159777     DOI: 10.1093/hmg/ddq072

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  16 in total

Review 1.  Bacterial type III secretion system as a protein delivery tool for a broad range of biomedical applications.

Authors:  Fang Bai; Zhenpeng Li; Akihiro Umezawa; Naohiro Terada; Shouguang Jin
Journal:  Biotechnol Adv       Date:  2018-02-02       Impact factor: 14.227

2.  Efficient Gene Editing in Pluripotent Stem Cells by Bacterial Injection of Transcription Activator-Like Effector Nuclease Proteins.

Authors:  Jingyue Jia; Fang Bai; Yongxin Jin; Katherine E Santostefano; Un-Hwan Ha; Donghai Wu; Weihui Wu; Naohiro Terada; Shouguang Jin
Journal:  Stem Cells Transl Med       Date:  2015-06-10       Impact factor: 6.940

3.  Deficiency of the purine metabolic gene HPRT dysregulates microRNA-17 family cluster and guanine-based cellular functions: a role for EPAC in Lesch-Nyhan syndrome.

Authors:  Ghiabe-Henri Guibinga; Fiona Murray; Nikki Barron; William Pandori; Gorjan Hrustanovic
Journal:  Hum Mol Genet       Date:  2013-06-25       Impact factor: 6.150

4.  MicroRNA-mediated dysregulation of neural developmental genes in HPRT deficiency: clues for Lesch-Nyhan disease?

Authors:  Ghiabe-Henri Guibinga; Gorjan Hrustanovic; Kathryn Bouic; Hyder A Jinnah; Theodore Friedmann
Journal:  Hum Mol Genet       Date:  2011-10-31       Impact factor: 6.150

5.  Purine metabolism during neuronal differentiation: the relevance of purine synthesis and recycling.

Authors:  Martin Göttle; Heike Burhenne; Diane Sutcliffe; H A Jinnah
Journal:  J Neurochem       Date:  2013-08-18       Impact factor: 5.372

6.  Brain white matter volume abnormalities in Lesch-Nyhan disease and its variants.

Authors:  David J Schretlen; Mark Varvaris; Tracy D Vannorsdall; Barry Gordon; James C Harris; H A Jinnah
Journal:  Neurology       Date:  2014-12-10       Impact factor: 9.910

7.  Consequences of impaired purine recycling on the proteome in a cellular model of Lesch-Nyhan disease.

Authors:  Eric B Dammer; Martin Göttle; Duc M Duong; John Hanfelt; Nicholas T Seyfried; H A Jinnah
Journal:  Mol Genet Metab       Date:  2015-03-05       Impact factor: 4.797

8.  Transcriptomic approach to Lesch-Nyhan disease.

Authors:  Luce Dauphinot; Lionel Mockel; Julie Cahu; H A Jinnah; Morgan Ledroit; Marie-Claude Potier; Irène Ceballos-Picot
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2014       Impact factor: 1.381

9.  Erosion of dosage compensation impacts human iPSC disease modeling.

Authors:  Shila Mekhoubad; Christoph Bock; A Sophie de Boer; Evangelos Kiskinis; Alexander Meissner; Kevin Eggan
Journal:  Cell Stem Cell       Date:  2012-05-04       Impact factor: 24.633

10.  Physiological levels of folic acid reveal purine alterations in Lesch-Nyhan disease.

Authors:  José M López; Esther L Outtrim; Rong Fu; Diane J Sutcliffe; Rosa J Torres; H A Jinnah
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.